Qiagen N.V. (QGEN) said Monday that it has acquired Ingenuity Systems, Inc., a privately-held U.S. company that provides software solutions to efficiently and accurately analyze and interpret the biological meaning of genomic data, for $105 million in cash, subject to customary purchase price adjustments.
The acquisition of Ingenuity, which had 2012 net sales of about $20 million, was funded from existing cash reserves.
In 2013, Qiagen expects to report adjusted net sales of about $15 million from Ingenuity, which excludes fair value adjustments to acquired deferred revenue related to sales contracts executed by Ingenuity prior to the acquisition.
The deal is expected to be dilutive to full-year 2013 adjusted diluted EPS by about $0.03 per share and to 2014 adjusted diluted EPS by about $0.02 per share, and become accretive in 2015, Qiagen said.
For comments and feedback: editorial@rttnews.com